Literature DB >> 10487262

Awake aortic aneurysm repair in patients with severe pulmonary disease.

W E McGregor1, A J Koler, G C Labat, V Perni, M K Hirko, J R Rubin.   

Abstract

BACKGROUND: We report the use of retroperitoneal aortic aneurysm repair utilizing exclusive regional anesthesia (no intubation or inhalation anesthetic) in high pulmonary risk patients.
METHODS: Six patients were retrospectively reviewed. Pulmonary disease was diagnosed by clinical history and pulmonary function tests. Patients received intravenous sedation and regional anesthesia. Retroperitoneal aortoiliac aneurysm repair was performed.
RESULTS: All patients used inhaled steroids and albuterol. Three required theophylline and home oxygen. FEV1 = 23% +/- 5% predicted, FVC = 34% +/- 5% predicted, and PO2 = 62 +/- 2 mm Hg. Operative time was 247 +/- 25 minutes. Blood loss was 840 +/- 479 mL. Five of six patients (83%) tolerated awake aneurysm repair and had intensive care unit stays of 2.4 +/- 0.6 days, and postoperative hospital stays of 8.2 +/- 1.8 days. One patient was converted to general anesthesia and had a prolonged hospital stay.
CONCLUSIONS: With thorough patient communication, awake retroperitoneal aortic aneurysm repair can be safely performed in select patients with severe pulmonary disease.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10487262     DOI: 10.1016/s0002-9610(99)00153-1

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  3 in total

1.  Awake nonresectional lung volume reduction surgery.

Authors:  Tommaso Claudio Mineo; Eugenio Pompeo; Davide Mineo; Frederico Tacconi; Mario Marino; Alessandro Fabrizio Sabato
Journal:  Ann Surg       Date:  2006-01       Impact factor: 12.969

2.  Open Abdominal Aortic Aneurysm Replacement in the Awake Patient.

Authors:  L Meecham; A Torrance; S Vijay; A Burtenshaw; R Downing
Journal:  Int J Angiol       Date:  2015-04-13

3.  Anesthetic management of a pediatric patient with severe Williams-Campbell syndrome undergoing surgery for giant ovarian tumor.

Authors:  Satoshi Toyama; Fumimaro Hatori; Ayako Shimizu; Toshio Takagi
Journal:  J Anesth       Date:  2008-05-25       Impact factor: 2.078

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.